Nazon, C.; Sabo, A.-N.; Becker, G.; Lessinger, J.-M.; Kemmel, V.; Paillard, C.
Optimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach. J. Clin. Med. 2019, 8, 1701.
https://doi.org/10.3390/jcm8101701
AMA Style
Nazon C, Sabo A-N, Becker G, Lessinger J-M, Kemmel V, Paillard C.
Optimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach. Journal of Clinical Medicine. 2019; 8(10):1701.
https://doi.org/10.3390/jcm8101701
Chicago/Turabian Style
Nazon, Charlotte, Amelia-Naomi Sabo, Guillaume Becker, Jean-Marc Lessinger, Véronique Kemmel, and Catherine Paillard.
2019. "Optimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach" Journal of Clinical Medicine 8, no. 10: 1701.
https://doi.org/10.3390/jcm8101701
APA Style
Nazon, C., Sabo, A.-N., Becker, G., Lessinger, J.-M., Kemmel, V., & Paillard, C.
(2019). Optimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach. Journal of Clinical Medicine, 8(10), 1701.
https://doi.org/10.3390/jcm8101701